Literature DB >> 12783498

A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate.

Bernhard Pfeiffer1, Elisabetta Peduzzi, Kerstin Moehle, Rinaldo Zurbriggen, Reinhard Glück, Gerd Pluschke, John A Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12783498     DOI： 10.1002/anie.200250348

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  9 in total

1.  Identification of a highly conserved surface on Tat variants.

Authors:  Sonia Mediouni; Albert Darque; Isabelle Ravaux; Gilbert Baillat; Christian Devaux; Erwann P Loret
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

Review 2.  Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.

Authors:  Nicole Westerfeld; Gerd Pluschke; Rinaldo Zurbriggen
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

Review 3.  Peptides for Vaccine Development.

Authors:  Ian W Hamley
Journal:  ACS Appl Bio Mater       Date:  2022-02-23

4.  Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens.

Authors:  Itziar Ubillos; Joseph J Campo; Alfons Jiménez; Carlota Dobaño
Journal:  Malar J       Date:  2018-05-29       Impact factor: 2.979

Review 5.  Development of designed site-directed pseudopeptide-peptido-mimetic immunogens as novel minimal subunit-vaccine candidates for malaria.

Authors:  José Manuel Lozano; Liliana P Lesmes; Luisa F Carreño; Gina M Gallego; Manuel Elkin Patarroyo
Journal:  Molecules       Date:  2010-12-06       Impact factor: 4.411

6.  Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine.

Authors:  Marco Tamborrini; Markus S Mueller; Sabine A Stoffel; Nicole Westerfeld; Denise Vogel; Francesca Boato; Rinaldo Zurbriggen; John A Robinson; Gerd Pluschke
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

7.  T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamics.

Authors:  Elena Topchiy; Geoffrey S Armstrong; Katherine I Boswell; Ginka S Buchner; Jan Kubelka; Teresa E Lehmann
Journal:  Malar J       Date:  2013-03-18       Impact factor: 2.979

8.  A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.

Authors:  Blaise Genton; Gerd Pluschke; Lukas Degen; Andreas R Kammer; Nicole Westerfeld; Shinji L Okitsu; Sandro Schroller; Penelope Vounatsou; Markus M Mueller; Marcel Tanner; Rinaldo Zurbriggen
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

9.  A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

Authors:  Shinji L Okitsu; Olivier Silvie; Nicole Westerfeld; Marija Curcic; Andreas R Kammer; Markus S Mueller; Robert W Sauerwein; John A Robinson; Blaise Genton; Dominique Mazier; Rinaldo Zurbriggen; Gerd Pluschke
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.